MissionIR Articles

Cempra is a clinical-stage pharmaceutical company engaged in developing antibiotics to meet critical needs in treating bacterial infectious diseases. The company’s two lead product candidates, solithromycin and CEM-102, are currently in advanced clinical development –…

Inovio Pharmaceuticals is revolutionizing vaccines for the prevention and treatment of today’s cancers and infectious diseases. The company’s SynCon vaccines are designed to provide universal cross-strain protection against both known and newly emergent unmatched strains…

Neuralstem possesses patented technology that enables the production of neural stem cells of the human brain and spinal cord in commercial quantities, as well as the ability to control the differentiation of these cells into…

Resverlogix is a clinical-stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is currently developing RVX-208, which is a first-in-class small molecule for treating atherosclerosis and the first BET bromodomain…

Athersys is a clinical stage biopharmaceutical company focused on discovering and developing therapeutic product candidates for extending and enhancing human quality of life. The company is currently developing its MultiStem cell therapy product and has…

ImmunoGen is a biotechnology company developing targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, coupled with its expertise in monoclonal antibodies and tumor biology. A TAP compound delivers one of ImmunoGen’s purpose-developed cancer-killing…

Zalicus is a biopharmaceutical company engaged in discovering and developing novel treatments for patients suffering with pain. The company’s portfolio of proprietary clinical-stage product candidates has entered into various revenue-generating collaborations with large pharmaceutical companies…

Exelixis is a biotechnology company focused on the development of small molecule therapies to treat cancer. The company’s proprietary resources and development efforts are focused exclusively on COMETRIQ, its lead product. The company has additionally…

StemCells is a leading developer of cell-based therapeutics and tools for stem cell-based research and drug discovery. StemCells’ lead therapeutic product candidate, HuCNS-SC cells, is currently being developed as a potential treatment for various central…

Horizon Pharma is a biopharmaceutical company focused on the development and commercialization of innovative medicines to target unmet therapeutic needs in the areas of arthritis, pain and inflammatory diseases. The company’s strategy involves commercializing its…

Ohr Pharmaceutical is a pharmaceutical company focused on the clinical development of new drugs to address underserved therapeutic needs in markets that are large and growing. The company is currently focused on two lead compounds:…

Intercept Pharmaceuticals is a clinical-stage biopharmaceutical company utilizing its expertise in bile acid chemistry to develop and commercialize novel therapeutics for the treatment of orphan and more prevalent liver diseases. OCA (obeticholic acid), the company’s…

Tranzyme Pharma is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-based therapeutics to treat upper gastrointestinal motility disorders. Though more than 40 percent of people in the U.S. are affected…

Venaxis is an in vitro diagnostic company pursuing clinical development and commercialization of APPY1, its blood-based appendicitis test. Designed to aid in identifying patients at low risk for acute appendicitis, thus enabling more conservative patient…

Anthera Pharmaceuticals is a biopharmaceutical company engaged in developing and commercializing products for the treatment of serious illnesses, such as cardiovascular and autoimmune diseases. The company’s clinical-stage program includes a Phase 2 study of blisibimod,…

RXi Pharmaceuticals is a biotechnology company engaged in the discovery, development and commercialization of innovative therapies to address major unmet medical needs using RNA-targeted technologies. Building on the groundbreaking work of Nobel Laureate and RXi…

Catalyst Pharmaceutical Partners is a development-stage specialty pharmaceutical company engaged in developing and commercializing prescription drugs that target orphan drug diseases as well as disorders of the central nervous system. The company currently has three…

TG Therapeutics is a clinical-stage biopharmaceutical company engaged in acquiring, developing and commercializing pharmaceutical products that are medically important for the treatment of cancer and other underserved therapeutic needs. The company is currently developing two…